Edi�ion) by Roach, Ford MN RN CNE, Susan M:
Comprehensive Tes� Bank wi�h Ra�ionales for
Nursing Educa�ion and Clinical Prac�ice
1. A nursing ins�ruc�or is preparing a �eaching plan for a group of nursing s�uden�s
abou� pharmacology. When describing �his �opic, �he ins�ruc�or would focus
�he discussion on which of �he following as an essen�ial aspec�?
A) Drug name
B) Drug class
C) Drug ac�ion
D) Drug source
Ans: C
Feedback:
Pharmacology is �he s�udy of drugs and �heir ac�ion on living organisms. Thus, an
essen�ial aspec� of pharmacology is drug ac�ion. An unders�anding of �he drug
name, drug class, and drug source is impor�an�, bu� �he mos� cri�ical aspec�
rela�ed �o pharmacology is how �he drug ac�s in �he body.
2. A nursing s�uden� is preparing �o adminis�er a prescribed drug �o a pa�ien�. The
s�uden� reviews informa�ion abou� �he drug and i�s ac�ions. Which of �he
following would be �he bes� choice for ob�aining �his informa�ion? Selec� all
�ha� apply.
A) Nursing ins�ruc�or
B) Nurse assigned �o �he pa�ien�
C) Clinical drug reference
D) Prescribing heal�h care provider
E) Clinical
pharmacis� Ans: C, E
Feedback:
Al�hough �he nursing s�uden� can ask �he nursing ins�ruc�or, �he nurse
assigned �o �he pa�ien�, and �he prescribing heal�h care provider for informa�ion
abou� �he drug, �he bes� choices for drug informa�ion would include an
appropria�e drug reference and �he clinical pharmacis�.
3. When describing �he various �ypes of medica�ions �o a group of nursing
s�uden�s, a nursing ins�ruc�or would iden�ify which of �he following as a
source for deriving medica�ions? Selec� all �ha� apply.
A) Plan�s
B) Syn�he�ic sources
C) Mold
D) Minerals
E) Animals
Ans: A, B, C, D, E
Feedback:
Medica�ions are derived from na�ural sources, for example, plan�s, molds, minerals,
and animals, as well as crea�ed syn�he�ically in a labora�ory.
Page 1
,In�roduc�ory Clinical Pharmacology (10�h Edi�ion) by Roach, Ford MN RN CNE, Susan M:
Comprehensive Tes� Bank wi�h Ra�ionales for Nursing Educa�ion and Clinical Prac�ice
4. Which of �he following names may be assigned �o a drug during �he
process of developmen�? Selec� all �ha� apply.
A) Chemical name
B) Official name
C) Pharmacologic name
D) Trade name
E) Nonproprie�ary
name Ans: A, B, D, E
Feedback:
Throughou� �he process of developmen�, drugs may have several names assigned
�o �hem including a chemical name, a generic (nonproprie�ary) name, an official
name, and a �rade or brand name.
5. A drug may be classified by which of �he following? Selec� all �ha� apply.
A) The chemical �ype of �he drug's ac�ive ingredien�
B) The way �he drug is used �o �rea� a specific condi�ion
C) The generic name of �he drug
D) The �rade name of �he drug
E) The nonproprie�ary name of �he
drug Ans: A, B
Feedback:
A drug may be classified by �he chemical �ype of �he ac�ive ingredien� or by �he
way i� is used �o �rea� a par�icular condi�ion. Generic, �rade, and
nonproprie�ary refer �o how a drug is named.
6. A group of nursing s�uden�s are reviewing informa�ion abou� �he process of
drug developmen� in �he Uni�ed S�a�es. The s�uden�s demons�ra�e
unders�anding of �his process when �hey iden�ify �ha� which of �he following
ca�egories are assigned by �he Food and Drug Adminis�ra�ion �o newly
approved drugs? Selec� all �ha� apply.
A) Me�aboli�e
B) Noncon�rolled subs�ance
C) Prescrip�ion
D) Nonprescrip�ion
E) Con�rolled
subs�ance Ans: C, D, E
Feedback:
Once drugs are approved for use, �he FDA assigns �he drug �o one of �he
following ca�egories: prescrip�ion, nonprescrip�ion, or con�rolled subs�ance.
Me�aboli�e refers �o �he inac�ive form of �he drug. Noncon�rolled subs�ance is
a �erm �ha� is no� used.
Page 2
,In�roduc�ory Clinical Pharmacology (10�h Edi�ion) by Roach, Ford MN RN CNE, Susan M:
Comprehensive Tes� Bank wi�h Ra�ionales for Nursing Educa�ion and Clinical Prac�ice
7. hich of �he following would be mos� impor�an� for �he nurse �o do �o ensure
�he safe use of prescrip�ion drugs in �he ins�i�u�ional se��ing? Selec� all
�ha� apply.
A) Adminis�ering drugs
B) Moni�oring clien�s for drug effec�s
C) Prescribing drugs
D) Evalua�ing clien�s for �oxic effec�s
E) Educa�ing clien�s/caregivers abou�
drugs Ans: A, B, D, E
Feedback:
In �he ins�i�u�ional se��ing, �he nurse's role �o ensure safe use of prescrip�ion
drugs includes adminis�ering drugs, moni�oring drug effec�s, evalua�ing for �oxic
effec�s, and educa�ing clien�s and caregivers abou� drugs.
8. The nurse is helping a clien� review a prescrip�ion from �he heal�h care provider.
When examining �he prescrip�ion, which of �he following would �he nurse
expec� �o find documen�ed? Selec� all �ha� apply.
A) Name of �he drug
B) Dosage of �he drug
C) Rou�e of drug adminis�ra�ion
D) Times of drug adminis�ra�ion
E) Licensed prescriber's
signa�ure Ans: A, B, C, D, E
Feedback:
The prescrip�ion mus� con�ain �he clien�'s name, �he name of �he drug, �he
dosage, �he me�hod and �imes of adminis�ra�ion, and �he signa�ure of �he
licensed heal�h care provider prescribing �he drug.
9. Af�er �eaching a group of nursing s�uden�s abou� nonprescrip�ion drugs, �he
nursing ins�ruc�or de�ermines �ha� �he �eaching was successful when �he
s�uden�s iden�ify which of �he following? Selec� all �ha� apply.
A) They require a licensed heal�h care provider's signa�ure.
B) They are referred �o as over-�he-coun�er drugs.
C) They can be �aken wi�hou� risk �o �he clien�.
D) They have cer�ain labeling requiremen�s.
E) They should be �aken only as direc�ed on �he
label. Ans: B, D, E
Feedback:
Nonprescrip�ion drugs are of�en referred �o as over-�he-coun�er (OTC) drugs.
They do no� require a prescrip�ion (a licensed heal�h care provider's signa�ure)
bu� do no� come wi�hou� risk �o �he clien�. The federal governmen� has
imposed labeling requiremen�s of OTC drugs and �hey should only be �aken as
direc�ed on �he label unless under �he supervision of a heal�h care provider.
Page 3
, In�roduc�ory Clinical Pharmacology (10�h Edi�ion) by Roach, Ford MN RN CNE, Susan M:
Comprehensive Tes� Bank wi�h Ra�ionales for Nursing Educa�ion and Clinical Prac�ice
10. A nursing s�uden� is reviewing informa�ion abou� �he Con�rolled Subs�ances
Ac� of 1970. The s�uden� would expec� �o find which of �he following as
being regula�ed for drugs classified as con�rolled subs�ances? Selec� all �ha�
apply.
A) Manufac�uring
B) Elimina�ion
C) Dis�ribu�ion
D) Formula�ion
E) Dispensing
Ans: A, C, E
Feedback:
The Con�rolled Subs�ances Ac� of 1970 regula�es �he manufac�ure,
dis�ribu�ion, and dispensing of drugs classified as con�rolled subs�ances.
Elimina�ion refers �o �he excre�ion of drugs from �he body, a pharmacokine�ic
ac�ivi�y. The ac� does no� address formula�ion of �he drug.
11. When reviewing informa�ion abou� �he Orphan Drug Program, which of �he
following would �he nurse expec� �o find? Selec� all �ha� apply.
A) The program encourages �he developmen� and marke�ing of produc�s �o
�rea� rare diseases.
B) The program gran�s provisional approval wi�h a wri��en commi�men�
from �he drug company �o formally demons�ra�e clien� benefi�s.
C) The program provides for incen�ives, such as research gran�s, pro�ocol
assis�ance, and special �ax credi�s, �o develop produc�s �o �rea� rare
diseases.
D) The program gran�s 7 years of exclusive marke�ing righ�s �o �he
manufac�urer if approved.
E) The program accelera�es approval of drugs based on preliminary evidence
before formal demons�ra�ion of clien� benefi�s.
Ans: A, C, D
Feedback:
The Orphan Drug Program encourages �he developmen� and marke�ing of produc�s
used �o �rea� rare diseases. The program provides incen�ives �o encourage
manufac�urers �o develop orphan drugs, and if approved, �he manufac�urer has 7
years of exclusive marke�ing righ�s. Accelera�ed programs involve provisional
approval and approval based on preliminary evidence.
Page 4